SCHEMBL22010988

SCHEMBL22010988

CCCCc1ccc(-c2ccc(-c3cc4oc5cc(-c6ccc(OCC)c(F)c6F)c(F)c(F)c5c4c(F)c3F)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 4/20 0.37
S1PR1 P21453 5/20 0.36
S1PR3 Q99500 4/20 0.36
RARB P10826 4/20 0.36
FFAR4 Q5NUL3 1/20 0.35
MAPT P10636 2/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
RARA P10276 1/20 0.33
RARG P13631 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ABCB1 P08183 1/20 0.33
S1PR5 Q9H228 1/20 0.33
EIF4A1 P60842 1/20 0.32
FGFR1 P11362 1/20 0.32
FGFR2 P21802 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010835 0.89 RARB (0.40) MPLRARBFFAR4MAPTRAB9A
SCHEMBL22010955 0.87 RARB (0.40) S1PR1S1PR3RARBFFAR4MAPT
SCHEMBL22902901 0.84 MPL (0.45) MPLS1PR1S1PR3RARBFFAR4
SCHEMBL21562904 0.84 MPL (0.42) MPLRARBFFAR4MAPTRAB9A
SCHEMBL22010820 0.84 RARB (0.40) MPLS1PR1RARBABCB1
SCHEMBL16772341 0.84 MPL (0.40) MPLS1PR1S1PR3RARBFFAR4
SCHEMBL22011803 0.83 CALM1 (0.35) MPLS1PR1S1PR3FFAR4MAPT
SCHEMBL11953529 0.83 MPL (0.43) MPLS1PR1S1PR3RARBFFAR4
SCHEMBL22010998 0.83 RARB (0.44) MPLS1PR1S1PR3RARBMAPT
SCHEMBL20936124 0.82 MPL (0.42) MPLS1PR1S1PR3RARBFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 MPL 4759/4885S1PR1 1710/4885S1PR3 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.